Tuberculosis as part of the natural history of HIV infection in developing countries.
An enhanced, refocused research agenda is critical to reducing the burden of tuberculosis (TB) in the human immunodeficiency virus (HIV) epidemic in developing countries. TB threatens HIV-infected patients before and after initiation of antiretroviral therapy, is difficult to diagnose, is rapidly fatal when it is drug resistant, and is being spread in clinics and hospitals. Research priorities include improved and point-of-care TB diagnostics; TB treatment and prevention during HIV infection, drug-resistant TB, and childhood TB; and optimization of TB and HIV program integration. With new TB diagnostics and drugs reaching approval, research must focus on effectively deploying these advancements. Research must include evaluations of individual, household, health care, and community approaches. Studies must apply implementation science to determine how to increase and adapt effective interventions to reduce TB burden in the context of HIV infection. Investment in this research will improve the lives of persons infected with HIV and contribute to efforts to reduce the global TB burden.
Chamie
Gabriel
G
HIV/AIDS Division, San Francisco General Hospital, University of California, San Francisco, USA. gabriel.chamie@ucsf.edu
Luetkemeyer
Annie
A
Charlebois
Edwin
E
Havlir
Diane V
DV
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000453:epidemiology* / Q000517:prevention & control; D035843:Biomedical Research / Q000639:trends*; D003140:Communicable Disease Control / Q000379:methods; D003906:Developing Countries; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy / Q000453:epidemiology* / Q000517:prevention & control; D006801:Humans; D014376:Tuberculosis / Q000188:drug therapy / Q000453:epidemiology* / Q000517:prevention & control
JAMA. 2004 Jun 2;291(21):2639-41
15173158
Int J Tuberc Lung Dis. 2009 Jun;13(6):767-74
19460255
Lancet. 1985 Oct 19;2(8460):849-52
2864575
J Infect Dis. 2009 Apr 1;199(7):982-90
19236280
Ann Intern Med. 2000 Nov 21;133(10):779-89
11085840
BMC Infect Dis. 2006 Apr 04;6:67
16595008
Am J Respir Crit Care Med. 2001 Jul 1;164(1):7-12
11435232
Am Rev Respir Dis. 1962 Apr;85:511-25
14492300
Curr Opin Infect Dis. 2008 Oct;21(5):454-61
18725793
Lancet. 2004 Dec 18-31;364(9452):2196-203
15610806
Lancet. 2006 Nov 4;368(9547):1575-80
17084757
Science. 1986 Nov 21;234(4779):955-63
3022379
Int J Tuberc Lung Dis. 2008 Dec;12(12):1376-9
19017445
JAMA. 2005 Jun 8;293(22):2719-25
15941800
Int J Tuberc Lung Dis. 2007 Feb;11(2):168-74
17263287
AIDS. 2001 Nov 9;15(16):2137-47
11684933
Lancet. 2002 Jun 15;359(9323):2059-64
12086758
J Med Microbiol. 2008 Apr;57(Pt 4):439-443
18349362
Am J Respir Crit Care Med. 2008 Apr 1;177(7):787-92
18202343
AIDS. 1999 Mar 11;13(4):501-7
10197379
Clin Infect Dis. 2008 Jul 1;47(1):8-14
18484876
JAMA. 2008 Aug 6;300(5):530-9
18677025
J Clin Microbiol. 2007 Jun;45(6):1936-40
17392443
Scand J Infect Dis. 2002;34(5):331-7
12069014
Clin Infect Dis. 1997 Aug;25(2):242-6
9332519
Am J Respir Crit Care Med. 2007 Jan 1;175(1):87-93
16973982
Infect Control Hosp Epidemiol. 2003 Jul;24(7):483-9
12887235
Clin Infect Dis. 2009 Jun 15;48(12):1752-9
19438397
BMC Public Health. 2008 Feb 21;8:68
18289392
J Acquir Immune Defic Syndr. 2009 Jan 1;50(1):37-43
19295333
PLoS One. 2008 Feb 06;3(2):e1536
18253484
J Infect Dis. 2007 Aug 15;196 Suppl 1:S86-107
17624830
Lancet. 2006 Mar 18;367(9514):945-7
16546546
Ann Trop Paediatr. 2008 Mar;28(1):3-12
18318944
Clin Infect Dis. 2009 Mar 15;48(6):829-31
19207078
AIDS. 2002 Jan 4;16(1):75-83
11741165
AIDS. 2009 Jan 28;23(3):335-42
19114870
Lancet Infect Dis. 2006 Sep;6(9):570-81
16931408
Thorax. 2006 Sep;61(9):783-90
16738037
J Acquir Immune Defic Syndr. 2009 Apr 15;50(5):537-45
19223783
Trans R Soc Trop Med Hyg. 2005 Dec;99(12):893-900
16139316
Trans R Soc Trop Med Hyg. 2009 Jun;103(6):638-40
19036392
JAMA. 2008 Jul 23;300(4):423-30
18647985
J Acquir Immune Defic Syndr. 2000 May 1;24(1):23-9
10877491
Paediatr Respir Rev. 2007 Jun;8(2):142-7
17574158
PLoS Med. 2007 Feb;4(2):e68
17326709
J Infect Dis. 2008 Jun 1;197(11):1493-8
18426366
BMJ. 2007 Jan 20;334(7585):136
17085459
Scand J Infect Dis. 2008;40(1):30-5
17852913
HIV Med. 2008 May;9(5):294-9
18400076
Am J Respir Crit Care Med. 2003 Feb 15;167(4):603-62
12588714
Int J Tuberc Lung Dis. 2005 Mar;9(3):248-57
15786886
N Engl J Med. 2009 Jun 4;360(23):2397-405
19494215
Arch Intern Med. 2003 May 12;163(9):1009-21
12742798
J Infect Dis. 2007 Aug 15;196 Suppl 1:S46-51
17624825
Am J Respir Crit Care Med. 2000 May;161(5):1713-9
10806179
Am J Epidemiol. 1995 Jul 1;142(1):3-14
7785671
J Infect Dis. 2007 Aug 15;196 Suppl 1:S15-27
17624822
Am J Respir Crit Care Med. 2008 Apr 1;177(7):680-5
18202347
Curr Opin Infect Dis. 2009 Apr;22(2):174-82
19283913
Int J Tuberc Lung Dis. 2002 Jan;6(1):55-63
11931402
Science. 2007 Dec 14;318(5857):1728-9
18079386
Am J Respir Crit Care Med. 2007 Jun 1;175(11):1199-206
17290042
Scand J Immunol. 2006 Sep;64(3):243-50
16918693